资讯

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock gain as Trump administration to trial Medicare, Medicaid coverage for ...
According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...
Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
The Trump administration is exploring a five-year pilot program to include weight-loss drugs like Wegovy, Ozempic, Zepbound, ...
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
Throughout the country, pediatricians say anxious parents are concerned about access to routine childhood immunizations, ...
As changes to Medicaid funding and enrollment requirements come into effect over the next few years, the Minnesota Department ...
Changes to Medicaid could leave thousands of South Dakotans uninsured and impair an already fragile rural health care system, ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday.